Envestnet Asset Management’s ADMA Biologics ADMA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.61M | Buy |
143,229
+74,543
| +109% | +$1.36M | ﹤0.01% | 2645 |
|
2025
Q1 | $1.36M | Buy |
68,686
+8,682
| +14% | +$172K | ﹤0.01% | 2984 |
|
2024
Q4 | $1.03M | Buy |
60,004
+24,293
| +68% | +$417K | ﹤0.01% | 3155 |
|
2024
Q3 | $714K | Buy |
35,711
+22,595
| +172% | +$452K | ﹤0.01% | 3313 |
|
2024
Q2 | $147K | Buy |
13,116
+1,929
| +17% | +$21.6K | ﹤0.01% | 4003 |
|
2024
Q1 | $73.8K | Buy |
+11,187
| New | +$73.8K | ﹤0.01% | 4085 |
|
2023
Q4 | – | Sell |
-22,245
| Closed | -$79.6K | – | 4045 |
|
2023
Q3 | $79.6K | Buy |
22,245
+4,814
| +28% | +$17.2K | ﹤0.01% | 3899 |
|
2023
Q2 | $64.3K | Buy |
17,431
+6,989
| +67% | +$25.8K | ﹤0.01% | 3860 |
|
2023
Q1 | $34.6K | Buy |
+10,442
| New | +$34.6K | ﹤0.01% | 3890 |
|